查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1908203

人工智慧在心臟病学领域的市场规模、份额和趋势分析报告：按组件、应用、疾病、地区和细分市场预测（2026-2033 年）

AI In Cardiology Market Size, Share & Trends Analysis Report By Component, By Application, By Medical Condition, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

人工智慧在心臟病学领域的市场概览

2025年全球心臟病学人工智慧市场规模估计为16.9亿美元，预计到2033年将达到148.3亿美元。

预计从 2026 年到 2033 年，其复合年增长率将达到 31.17%。全球心血管疾病盛行率的上升，加上心臟科医师对提高诊断准确性的日益重视以及心臟影像技术的快速发展，是推动人工智慧在心臟病学领域应用不断扩展的主要因素。

例如，Sensidia公司于2023年5月宣布开发出心臟功能检测系统（CPS），该系统利用生物感测器和人工智慧技术来检测心臟异常。该公司已成功资金筹措800万美元资金，用于进一步推进其技术研发。

推动人工智慧产业在心臟病学领域发展的关键因素是心血管疾病（CVD）发病率的上升趋势以及由此产生的高效医疗解决方案的需求。世界卫生组织（WHO）指出，心血管疾病仍是全球首要死因。例如，预计2022年将有1,980万人死于心血管疾病，约占全球死亡总数的32%。同样，根据美国疾病管制与预防中心（CDC）预测，2023年将有919,032人死于心血管疾病，占总死亡人数的三分之一。日益沉重的疾病负担迫切需要开发和应用先进技术，以改善疾病管理和患者预后。

高血压、冠状动脉疾病、心臟衰竭和心律不整等疾病的高发给全球医疗保健系统带来了沉重负担。传统的诊断和治疗方法往往耗时费力，且可能缺乏提供最佳患者照护所需的准确性。人工智慧透过提高心血管疾病检测、诊断和管理的准确性和效率，提供了一种变革性的解决方案。

此外，人工智慧在心臟病学领域的应用将促进个人化医疗的实现。透过分析个别患者数据，人工智慧可以帮助制定针对每位患者独特需求和病情的个人化治疗方案。例如，在心臟衰竭的治疗中，人工智慧可以根据每位患者的特定疾病特征和对先前治疗的反应，帮助确定最有效的药物组合和生活方式调整方案。这种个人化方法可以提高介入措施的有效性，并改善患者的整体生活品质。

人工智慧演算法和成像技术的进步正在推动市场成长。先进的机器学习和深度学习演算法的开发彻底改变了人工智慧在医学成像领域的能力。这些先进演算法现在能够高精度地处理大量数据，从而实现心血管疾病的早期检测、精准诊断和个人化治疗方案。例如，UltraSight于2024年6月与梅奥诊所合作开发了一款由人工智慧驱动的心臟影像解决方案。这项合作的重点是开发演算法，以增强照护现场超音波在心臟评估中的应用。同样，HeartEye Diagnostics于2025年2月开发了“Dr. Noon CVD”，这是一款用于心血管疾病风险评估的人工智慧驱动的视网膜成像系统。该系统使用非侵入性视网膜影像，取代了CT扫描和血液检查，可在三分钟内提供结果，其准确性与心臟电脑断层扫描相当。

此外，人工智慧在心臟病学市场的成长主要得益于策略性倡议的增加和Start-Ups资金筹措的激增。诸如伙伴关係、新产品发布、协作和收购等策略性倡议促进了创新，并加速了人工智慧解决方案在心臟病学领域的开发和应用。例如，2024年5月，iHridAI推出了HarmonyCVI，这是一款旨在实现全面、精准心血管诊断的创新产品。 HarmonyCVI是一款先进的诊断和分析工具，利用人工智慧和机器学习技术，帮助心臟科医生和放射科医生更好地解读心臟磁振造影（MRI）影像。同样，2024年9月，雅培与iCardio.ai合作开发人工智慧成像解决方案，旨在改善心血管诊断。这些措施通常旨在将人工智慧整合到现有的医疗保健基础设施中，以提高诊断准确性并改善患者预后。

应用案例洞察：RSIP Vision 利用 AI 驱动的胸部 CT 分割加速手术导引

RSIP Vision 开发了一种先进的基于人工智慧的解决方案，能够根据电脑断层扫描自动为每位患者产生复杂胸腔解剖结构的高解析度 3D 模型。这些模型对于规划复杂的手术导航流程至关重要，透过精确的解剖视觉化，能够实现更安全、更有效的手术介入。传统的解决方案速度慢、稳定性差，且需要大量的人工编辑，加重了临床工作流程的负担。

目录

第一章调查方法和范围

第二章执行摘要

3. 心臟病学领域人工智慧的市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 用例洞察
  • 心臟病学领域的人工智慧市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章 心臟病学领域的人工智慧市场：按组件分類的估算和趋势分析

  • 全球心臟病学人工智慧市场组成部分差异分析
  • 全球心臟病学人工智慧市场规模及趋势分析（按组件划分，2021-2033 年）
  • 软体
  • 硬体
  • 服务

第五章 人工智慧在心臟病学领域的市场应用、预测与趋势分析

  • 全球心臟病学人工智慧应用趋势分析
  • 2021-2033年全球心臟病学人工智慧市场规模及应用趋势分析
  • 诊断
  • 预言
  • 药物发现
  • 其他的

第六章 心臟病学领域的人工智慧市场：依疾病分类、估算与趋势分析

  • 全球心臟病学人工智慧市场疾病趋势分析
  • 全球心臟病学人工智慧市场规模及趋势分析（按疾病分类，2021-2033 年）
  • 心律不整
  • 心臟衰竭
  • 缺血性心臟疾病/冠状动脉疾病
  • 其他的

7. 心臟病学领域的人工智慧市场：区域、估算和趋势分析

  • 区域市场占有率分析（2025 年和 2033 年）
  • 区域市场概览
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 公司/竞争对手分类
  • 策略规划
  • 2025年商业市场分析
  • 公司简介/列表
    • GE Healthcare
    • Heartflow, Inc.
    • IDOVEN
    • CardiAI
    • Ultromics Limited
    • Arterys Inc.（Tempus AI）
    • Ultrasight
    • Koninklijke Philips NV
    • Vista AI
    • Viz.ai, Inc.
    • RSIP Vision
    • Cleerly, Inc.
    • Medical AI Co., Ltd.
    • anumana, Inc.
    • Aidoc
    • Circle Cardiovascular Imaging Inc.
    • Eko Health, Inc.
    • cardiomatics.com
Product Code: GVR-4-68040-047-1

AI In Cardiology Market Summary

The global AI in cardiology market size was estimated at USD 1.69 billion in 2025 and is projected to reach USD 14.83 billion by 2033, growing at a CAGR of 31.17% from 2026 to 2033. The rising global prevalence of cardiovascular diseases, coupled with the increasing focus of cardiac specialists on enhancing diagnostic precision and rapid advancements in cardiac imaging technology, are among the key factors responsible for expanding the applications of AI in cardiology.

For instance, in May 2023, Sensydia announced the development of its Cardiac Performance System (CPS), which uses biosensors and AI to detect heart abnormalities. The company secured USD 8 million in funding to advance its technology.

A primary factor driving the growth of the artificial intelligence in cardiology industry is the increasing prevalence of cardiovascular diseases (CVDs) and the consequent need for efficient & effective healthcare solutions. According to the WHO, CVD remains the leading cause of mortality worldwide. For instance, an estimated 19.8 million people died from CVDs in 2022, representing approximately 32% of all global deaths. Similarly, according to the Centers for Disease Control and Prevention (CDC), 919,032 people died from cardiovascular disease in the U.S. in 2023, equivalent to one in every three deaths. This escalating burden necessitates the development and implementation of advanced technologies to improve disease management and patient outcomes.

The high prevalence of conditions such as hypertension, coronary artery disease, heart failure, and arrhythmia puts a substantial strain on healthcare systems globally. Traditional diagnostic & treatment methods are often time-consuming & resource-intensive and are likely to lack the precision required for optimal patient care. AI offers a transformative solution by enhancing the accuracy and efficiency of CVD detection, diagnosis, and management.

Moreover, the integration of AI in cardiology facilitates the delivery of personalized medicine. By analyzing individual patient data, AI helps tailor treatment plans to address the unique needs and conditions of each patient. For instance, in managing heart failure, AI helps determine the most effective combination of medications and lifestyle modifications for each patient based on their specific disease profile and response to previous treatments. This personalized approach enhances the efficacy of interventions and improves patients' overall quality of life.

Technological advancements in AI algorithms and imaging techniques significantly drive the market growth. The development of advanced machine learning and deep learning algorithms has revolutionized the capabilities of AI in medical imaging and diagnostics. These advanced algorithms can now process vast amounts of data with high precision, allowing early detection, accurate diagnosis, and personalized treatment plans for CVDs. For instance, in June 2024, UltraSight partnered with Mayo Clinic to advance AI-driven cardiac imaging solutions. The collaboration focuses on developing algorithms that enhance point-of-care ultrasound for cardiac assessments. Similarly, in February 2025, Heart Eye Diagnostics developed Dr.Noon CVD, an AI-driven retinal imaging system for cardiovascular disease (CVD) risk assessment. Using noninvasive retinal images instead of CT or blood tests, it offers accuracy comparable to heart CT scans and delivers results in three minutes.

In addition,the growth of AI in cardiology market is significantly propelled by the rise in strategic initiatives and the surge in startup funding. Strategic initiatives, including partnerships, new launches, collaborations, & acquisitions, foster innovation and accelerate the development & deployment of AI solutions in cardiology. For instance, in May 2024, iHridAI launched its novel, innovative product, HarmonyCVI, designed for thorough and precise cardiovascular diagnosis. HarmonyCVI is an advanced diagnostic and analysis tool that utilizes AI & machine learning to assist cardiologists and radiologists in the improved interpretation of cardiac MRI scans. Similarly, in September 2024, Abbott partnered with iCardio.ai to develop artificial intelligence imaging solutions to improve cardiovascular diagnostics. These initiatives are often aimed at integrating AI with existing healthcare infrastructure to enhance diagnostic accuracy and improve patient outcomes.

Case Study Insights: Accelerating Surgical Navigation through Ai-Driven Chest Ct Segmentation by RSIP Vision

RSIP Vision developed an advanced AI-based solution to automatically generate high-resolution 3D models of complex, patient-specific chest anatomies from CT scans. These models are crucial for planning intricate surgical navigation procedures, where precise anatomical visualization informs safer and more effective interventions. Conventional solutions were slow, lacked robustness, and required extensive manual editing, burdening clinical workflows.

Global AI In Cardiology Market Report Segmentation

This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global AI in cardiology market report based on component, application, medical condition, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Hardware
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnosis
  • Prediction
  • Drug Discovery
  • Others
  • Medical Condition Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiac Arrhythmias
  • Heart Failure
  • Ischemic Heart Disease /CAD
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Segment
    • 1.2.2. Application Segment
    • 1.2.3. Medical Condition Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Artificial Intelligence in Cardiology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing burden of cardiovascular diseases and the need for efficient healthcare solutions
      • 3.2.1.2. Increasing strategic initiatives in AI technologies
      • 3.2.1.3. Rapid technological advancements and growing adoption of remote patient monitoring solutions
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Highly regulated industry
      • 3.2.2.2. High implementation and procurement costs
      • 3.2.2.3. Shortage of healthcare personnel in information technology
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Case Study Insights
  • 3.4. Artificial Intelligence in Cardiology Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape
      • 3.4.2.6. Social Landscape

Chapter 4. Artificial Intelligence in Cardiology Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Artificial Intelligence in Cardiology Market Component Movement Analysis
  • 4.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Hardware
    • 4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Artificial Intelligence in Cardiology Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Artificial Intelligence in Cardiology Market Application Movement Analysis
  • 5.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Diagnosis
    • 5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Prediction
    • 5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Drug Discovery
    • 5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Artificial Intelligence in Cardiology Market: Medical Condition Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Artificial Intelligence in Cardiology Market Medical Condition Movement Analysis
  • 6.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Medical Condition, 2021 to 2033 (USD Million)
  • 6.4. Cardiac Arrhythmias
    • 6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Heart Failure
    • 6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Ischemic Heart Disease /CAD
    • 6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Artificial Intelligence in Cardiology Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. GE Healthcare
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Technology type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Heartflow, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Technology type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. IDOVEN
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Technology type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. CardiAI
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Technology type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Ultromics Limited
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Technology type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Arterys Inc. (Tempus AI)
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Technology type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Ultrasight
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Technology type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Koninklijke Philips N.V.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Technology type benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Vista AI
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Technology type benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Viz.ai, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Technology type benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. RSIP Vision
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Technology type benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Cleerly, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Technology type benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Medical AI Co., Ltd.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Technology type benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. anumana, Inc.
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Technology type benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. Aidoc
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Technology type benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Circle Cardiovascular Imaging Inc.
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Technology type benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Eko Health, Inc.
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Technology type benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. cardiomatics.com
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Technology type benchmarking
      • 8.4.18.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 4 North America AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 6 U.S. AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 7 U.S. AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 9 Canada AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 10 Canada AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 11 Canada AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 12 Mexico AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 13 Mexico AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 14 Mexico AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 15 Europe AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 16 Europe AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 17 Europe AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 18 Europe AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 19 Germany AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 20 Germany AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 21 Germany AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 22 UK AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 23 UK AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 24 UK AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 25 France AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 26 France AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 27 France AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 28 Italy AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 29 Italy AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 30 Italy AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 31 Spain AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 32 Spain AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 33 Spain AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 34 Denmark AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 35 Denmark AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 36 Denmark AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 37 Sweden AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 38 Sweden AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 39 Sweden AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 40 Norway AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 41 Norway AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 42 Norway AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 43 North America AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 48 China AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 49 China AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 50 China AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 51 Japan AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 52 Japan AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 53 Japan AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 54 India AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 55 India AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 56 India AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 57 South Korea AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 58 South Korea AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 59 South Korea AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 60 Australia AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 61 Australia AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 62 Australia AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 63 Thailand AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 64 Thailand AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 65 Thailand AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 66 Latin America AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 67 Latin America AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 68 Latin America AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 69 Latin America AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 70 Brazil AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 71 Brazil AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 72 Brazil AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 73 Argentina AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 74 Argentina AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 75 Argentina AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 76 MEA AI in cardiology market, by region, 2021 - 2033 (USD Million)
  • Table 77 MEA AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 78 MEA AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 79 MEA AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 80 South Africa AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 81 South Africa AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 82 South Africa AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 86 UAE AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 87 UAE AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 88 UAE AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)
  • Table 89 Kuwait AI in cardiology market, by component, 2021 - 2033 (USD Million)
  • Table 90 Kuwait AI in cardiology market, by application, 2021 - 2033 (USD Million)
  • Table 91 Kuwait AI in cardiology market, by medical condition, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Artificial intelligence in cardiology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Commodity flow analysis
  • Fig. 5 Parent market analysis
  • Fig. 6 AI in Cardiology Market snapshot
  • Fig. 7 AI in Cardiology Market segment snapshot (Part 1)
  • Fig. 8 AI in Cardiology Market segment snapshot (Part 2)
  • Fig. 9 AI in Cardiology Market competitive landscape snapshot
  • Fig. 10 Market research process
  • Fig. 11 Parent market outlook (USD Billion) (2025)
  • Fig. 12 AI in cardiology market dynamics
  • Fig. 13 Few notable funding in AI in cardiology Market
  • Fig. 14 Comparison between AI-integrated healthcare and traditional healthcare
  • Fig. 15 AI in cardiology market: Porter's five forces analysis
  • Fig. 16 AI in cardiology market: PESTLE analysis
  • Fig. 17 Artificial intelligence in cardiology market, component outlook key takeaways (USD million)
  • Fig. 18 Artificial intelligence in cardiology market: Component movement analysis, 2025 & 2033 (USD Million)
  • Fig. 19 Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Artificial intelligence in cardiology market, application outlook key takeaways (USD Million)
  • Fig. 23 Artificial intelligence in cardiology market: Application movement analysis, 2025 & 2033 (USD Million)
  • Fig. 24 Diagnosis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Prediction market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Artificial intelligence in cardiology market, medical condition outlook key takeaways (USD Million)
  • Fig. 29 Artificial intelligence in cardiology market: Medical condition movement analysis, 2025 & 2033 (USD Million)
  • Fig. 30 Cardiac arrhythmias market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Heart failure market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Ischemic heart disease/CAD market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 AI in Cardiology Market: Regional outlook
  • Fig. 36 North America artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 U.S artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Canada artificial intelligence in cardiology software market, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Mexico artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 43 Europe artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 UK artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Germany artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 France artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Italy artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Spain artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Sweden artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Denmark artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Japan artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 China artificial intelligence in cardiology software market, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 India artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Australia artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Thailand artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 South Korea artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 73 Latin America artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Brazil artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Argentina artificial intelligence in cardiology software market, 2021 - 2033 (USD Million)
  • Fig. 78 MEA artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Africa artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Saudi Arabia artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 UAE artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Kuwait artificial intelligence in cardiology market, 2021 - 2033 (USD Million)
  • Fig. 87 Company Categorization
  • Fig. 88 Company market position/share analysis, 2025
  • Fig. 89 Strategic Framework